Glomerulus on a Chip Using Human Podocytes for Filtration Barrier Modeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current 3D models for chronic kidney disease (CKD) fail to effectively mimic the complex structure and function of the glomerular filtration barrier (GFB), lacking proper crosstalk between glomerular cells and using genetically modified cells with uncertain morphology and function.
Innovation Solution
A Glomerulus on a Chip (GOAC) device with human podocytes and glomerular endothelial cells seeded on Organoplates, devoid of artificial membranes, allowing natural cell interaction and long-term culture, maintaining phenotype and forming a functional GFB with selective permeability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If artificial membranes are used to separate cell layers in 3D models, then structural stability is improved, but biological functionality and cell crosstalk are reduced
Solution Approach 1:
The patent removes artificial membranes from the 3D model structure, extracting the problematic component that blocked cell crosstalk. By eliminating the membrane barrier, natural cell-to-cell communication and biological functionality are restored while maintaining structural integrity through alternative means such as extracellular matrix scaffolds and controlled microenvironment design.
Solution Approach 2:
The patent introduces extracellular matrix components and soluble factors as intermediary elements that facilitate cell interaction without requiring direct physical contact through membranes. These mediators transmit biochemical signals and structural support, enabling cell crosstalk while maintaining organizational structure in the absence of artificial membranes.
2Reliability
If genetically modified cells are used to enhance specific functions, then functional performance is improved, but morphology and physiological relevance become uncertain
Solution Approach 1:
The patent changes the cellular composition parameters by using primary human cells and immortalized cell lines with known characteristics instead of genetically modified cells. This parameter change maintains functional performance for studying specific kidney diseases while preserving natural morphology and physiological behavior, as the cells retain their native structural properties.
3Shape
If complex 3D structures are created to mimic glomerular architecture, then structural accuracy is improved, but manufacturing simplicity and scalability are reduced
Solution Approach 1:
The patent segments the glomerular model into distinct functional zones (filtration barrier, tubular structures, vascular components) that can be independently constructed and assembled. This segmentation allows complex 3D architecture to be achieved through modular assembly of simpler components, improving manufacturability and scalability while maintaining overall structural accuracy.
Solution Approach 2:
The patent employs microfluidic channel networks to create three-dimensional tissue architectures within a planar chip format. By utilizing the vertical dimension through stacked layers and horizontal dimension through channel networks, complex glomerular structures are replicated without requiring bulky three-dimensional construction, thereby simplifying manufacturing and enabling scalability.
4Reliability
If primary human cells are used to maintain physiological relevance, then biological accuracy is improved, but cell availability and culture stability are reduced
Solution Approach 1:
The patent performs preliminary characterization and validation of primary human cells before incorporating them into the 3D model, establishing their functional properties and stability parameters in advance. This preliminary action ensures that cells meet specific criteria for biological accuracy and culture stability, allowing long-term maintenance of physiologically relevant models with predictable performance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The GOAC device recapitulates the in vivo GFB function, including permselectivity and response to nephrotoxic compounds, and accurately models kidney diseases, enabling drug testing and disease modeling with high throughput and clinical relevance.
Implementation Method 1
The main function of glomeruli is to filter fluids and electrolytes from the blood, while retaining plasma proteins
Implementation Method 2
This activity happens at the level of the glomerular filtration barrier (GFB) and is coordinated by the interaction of two highly specialized glomerular cells
Data Source
AI summary
A glomerulus on a chip (GOAC) to recapitulate the human glomerular filtration barrier, the structure responsible for filtering the blood and preventing the loss of proteins, is provided using human podocytes and glomerular endothelial cells seeded into microfluidic chips. In long-term cultures, cells maintain their morphology, form capillary-like structures and express slit diaphragm proteins. This system recapitulates functions and structure of the glomerulus, including permselectivity. When exposed to sera from patients with anti-podocyte autoantibodies, the chips show albuminuria proportional to patients' proteinuria, phenomenon not observed with sera from healthy controls or individuals with primary podocyte defects. Also shown is its applicability for renal disease modeling and drug testing.